The pre- and post-authorisation data published by the European medicines agency on the use of biologics during pregnancy and lactation.
Nafise GhalandariR J E M DolhainJ M W HazesC L E SiezenJ W van der LaanH J M J CrijnsE P van PuijenbroekC J van der WoudePublished in: British journal of clinical pharmacology (2020)
In this article several suggestions are provided for improving a multidisciplinary approach to these issues. The initiation of suitable registries by marketing authorization holders and data transparency for clinicians and academics are highly endorsed.